PRIMAPRED 20MG BOX OF 20

Conditions or Diseases

1. Collagenoses and Connective Tissue Diseases

• Flare-ups of systemic diseases, notably:

  • Systemic lupus erythematosus

  • Vasculitis

  • Polymyositis

  • Visceral sarcoidosis

2. Dermatological

• Severe autoimmune blistering dermatoses (pemphigus, bullous pemphigoid)

• Severe forms of infantile hemangiomas

• Certain forms of lichen planus

• Certain acute urticarias

• Severe neutrophilic dermatoses

3. Digestive

• Flare-ups of:

  • Ulcerative colitis

  • Crohn’s disease

• Chronic active autoimmune hepatitis (with or without cirrhosis)

• Severe acute alcoholic hepatitis, histologically confirmed

4. Endocrine

• Severe subacute thyroiditis (De Quervain)

• Certain hypercalcemias

5. Hematological

• Severe immune thrombocytopenic purpura

• Autoimmune hemolytic anemias

• In combination with various chemotherapies for lymphoid malignant hematopathies

• Chronic erythroblastopenias, acquired or congenital

6. Infectious

• Tuberculous pericarditis and severe life-threatening forms of tuberculosis

• Pneumocystis carinii pneumonia with severe hypoxia

7. Neoplastic

• Antiemetic treatment during antineoplastic chemotherapy

• Edematous and inflammatory flare associated with antineoplastic treatments (radiotherapy and chemotherapy)

8. Nephrological

• Minimal change nephrotic syndrome

• Primary focal segmental glomerulosclerosis nephrotic syndrome

• Stage III and IV lupus nephropathy

• Intrarenal granulomatous sarcoidosis

• Vasculitis with renal involvement

• Primary extracapillary glomerulonephritis

9. Neurological

• Myasthenia

• Tumor-related cerebral edema

• Chronic idiopathic inflammatory polyradiculoneuritis

• Infantile spasms (West syndrome)

• Lennox-Gastaut syndrome

• Relapsing multiple sclerosis, following intravenous corticosteroid therapy

10. Ophthalmological

• Severe anterior and posterior uveitis

• Edematous exophthalmos

• Certain optic neuropathies, following intravenous corticosteroid therapy

  • (Oral therapy is not recommended as first-line in this indication)

11. ENT

• Certain serous otitis

• Nasosinusal polyposis

• Certain acute or chronic sinusitis

• Seasonal allergic rhinitis, short-term treatment

• Acute stridulous laryngitis (subglottic laryngitis) in children

12. Respiratory

• Persistent asthma (preferably short-term if inhaled high-dose therapy fails)

• Asthma exacerbations, especially severe acute asthma

• Chronic obstructive pulmonary disease (evaluation of reversibility of obstructive syndrome)

• Progressive sarcoidosis

• Diffuse interstitial pulmonary fibrosis

13. Rheumatological

• Rheumatoid arthritis and certain polyarthritis

• Polymyalgia rheumatica and Horton’s disease

• Acute rheumatic fever

• Severe and refractory cervicobrachial neuralgia

14. Organ and Hematopoietic Stem Cell Transplantation

• Prophylaxis or treatment of graft rejection

• Prophylaxis or treatment of graft-versus-host disease